BAY1142524
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY1142524, covering 2017-11-07 to 2022-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease [Phase 2]